The Michigan Alzheimer’s Disease Center is proud to be designated a Lewy Body Dementia (LBD) Research Center of Excellence by the Lewy Body Dementia Association (LBDA). The LBDA, the leading advocacy group dedicated to raising awareness and advancing research about LBD, announced this week the launch of the LBDA Research Centers of Excellence (RCOE). This partnership features 24 preeminent academic medical research centers across the United States, led by the Mayo Clinic.
The LBDA RCOE program will provide a centralized, coordinated research resource, supporting an expanded effort in conducting clinical trials related to LBD while helping to provide expert clinical care for patients, families and caregivers.
In addition to providing expanded clinical trials opportunities and expert clinical care, a large focus of the RCOE network will be on improving support and education services around the country for families and those living with LBD. Because of the Carl Rinne Lewy Body Dementia Initiative, U-M is a leader in Michigan in providing education, awareness, and support for those affected by LBD, which has helped tremendously in receiving this designation and has created the groundwork for a support group model that can be adapted around the country.